Emisphere announces big pharma partner backs out of late stage discussions for oral insulin partnership
Delivering the future
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005701767 / 2002-01-24
Date of Publication:
January 15, 2002
Date of Creation:
2002
Title:
Delivering the future : Emisphere, the oral delivery company : research report / Oren Levy.
Description:
22 p.
Variant title:
Delivering the future : Emisphere, the oral delivery company
Copyright Claimant:
White Mountain Capital, LLC (employer for hire of Oren Levy)
Names:
Oren Levy 1972-
White Mountain Capital, LLC (24 documents)
example document: White Mountain Capital, LLC research report
White Mountain Capital, LLC (24 documents)
example document: White Mountain Capital, LLC research report
|
Nabi Biopharmaceuticals
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005724353 / 2002-08-22
Date of Publication:
August 14, 2002
Date of Creation:
2002
Title:
Nabi Biopharmaceuticals : empowering the immune system : White Mountain Capital, LLC research report, released Aug. 14, 2002.
Description:
20 p.
Variant title:
Nabi Biopharmaceuticals : empowering the immune system : White Mountain Capital, LLC research report, released Aug. 14,
Copyright Claimant:
White Mountain Capital, LLC, (employer for hire of Oren Levy, 1972-, & Sidney VanNess, 1974-)
Names:
Oren Levy 1972-
Sidney VanNess 1974-
White Mountain Capital, LLC (24 documents)
example document: Upward bound
Sidney VanNess 1974-
White Mountain Capital, LLC (24 documents)
example document: Upward bound
Telik (TELK)
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005739497 / 2002-08-22
Date of Publication:
August 12, 2002
Date of Creation:
2002
Title:
Telik (TELK) : updated Aug. 12, 2002.
Basis of Claim:
New Matter: additional text.
Previous Registration:
Prev. reg. 2001 as Upward bound: evaluation of two small-cap biotechnology companies, TX 5-539-576.
Copyright Note:
C.O. correspondence.
Description:
1 v.
Variant title:
Telik (TELK) : updated Aug. 12, 2002.
Other Title:
Upward bound: evaluation of two small-cap biotechnology companies
Copyright Claimant:
White Mountain Capital, LLC
Names:
Emisphere (EMIS)
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005739498 / 2002-08-22
Date of Publication:
August 15, 2002
Date of Creation:
2002
Title:
Emisphere (EMIS) : updated Aug. 14, 2002.
Basis of Claim:
New Matter: additional material.
Previous Registration:
Prev. pub. 2002 as Emisphere, the oral delivery company.
Copyright Note:
C.O. correspondence.
Description:
1 v.
Number of similar titles:
2
Variant title:
Emisphere (EMIS) : updated Aug. 14, 2002.
Other Title:
Emisphere, the oral delivery company.
Copyright Claimant:
White Mountain Capital, LLC
Names:
White Mountain Capital, LLC (24 documents)
example document: White Mountain Capital, LLC research report
example document: White Mountain Capital, LLC research report
AtheroGenics
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005739660 / 2003-01-27
Date of Publication:
November 22, 2002
Date of Creation:
2002
Title:
AtheroGenics : rethinking inflammation.
Copyright Note:
C.O. correspondence.
Description:
19 p.
Number of similar titles:
2
Variant title:
AtheroGenics : rethinking inflammation.
Copyright Claimant:
White Mountain Capital
Names:
Amgen (AMGN)
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005748423 / 2003-04-15
Date of Publication:
February 16, 2003
Date of Creation:
2003
Title:
Amgen (AMGN) : reiterate buy rating after strong 4Q02 performance.
Application Title:
4Q02 updates of large cup biotech companies.
Basis of Claim:
New Matter: additions.
Description:
1 v.
Number of similar titles:
2
Variant title:
Amgen (AMGN) : reiterate buy rating after strong 4Q02 performance.
Other Title:
4Q02 updates of large cup biotech companies.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Emisphere (EMIS) 3Q02 update reiterate buy rating
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005748424 / 2003-04-15
Date of Publication:
February 16, 2003
Date of Creation:
2003
Title:
Emisphere (EMIS) 3Q02 update reiterate buy rating.
Application Title:
3Q02/4Q02 updates for emisphere (EMIS)
Basis of Claim:
New Matter: additions.
Description:
1 v.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Rigel (RIGL) 3Q02 update reiterate buy
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005748425 / 2003-04-15
Date of Publication:
February 25, 2003
Date of Creation:
2003
Title:
Rigel (RIGL) 3Q02 update reiterate buy.
Application Title:
2H03 updates: rigel.
Basis of Claim:
New Matter: additions.
Description:
1 v.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Nabi update 10/24/2002
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005748508 / 2003-04-15
Date of Publication:
October 24, 2002
Date of Creation:
2002
Title:
Nabi update 10/24/2002.
Application Title:
3Q02 Nabi update.
Basis of Claim:
New Matter: additions.
Previous Registration:
Preexisting material: Nabi biopharmaceuticals: right on target.
Description:
1 p.
Other Title:
Nabi biopharmaceuticals: right on target
Copyright Claimant:
White Mountain Capital, LLC
Names:
Biogen (BGEN) 1Q03 update
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867546 / 2003-10-07
Date of Publication:
April 21, 2003
Date of Creation:
2003
Title:
Biogen (BGEN) 1Q03 update : research report update, Apr. 21, 2003.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Variant title:
Biogen (BGEN) 1Q03 update : research report update, Apr. 21, 2003.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Rigel (RIGL) 1Q03 update
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867547 / 2003-10-07
Date of Publication:
May 13, 2003
Date of Creation:
2003
Title:
Rigel (RIGL) 1Q03 update : research report update, May 13, 2003.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Variant title:
Rigel (RIGL) 1Q03 update : research report update, May 13, 2003.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Emisphere (EMIS) 1Q03 update
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867548 / 2003-10-07
Date of Publication:
May 16, 2003
Date of Creation:
2003
Title:
Emisphere (EMIS) 1Q03 update : research report update, May 16, 2003.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Variant title:
Emisphere (EMIS) 1Q03 update : research report update, May 16, 2003.
Copyright Claimant:
White Mountain Capital, LLC
Names:
White Mountain Capital, LLC (24 documents)
example document: White Mountain Capital, LLC research report
example document: White Mountain Capital, LLC research report
Genentech announces 1Q03 earnings
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867549 / 2003-10-07
Date of Publication:
May 18, 2003
Date of Creation:
2003
Title:
Genentech announces 1Q03 earnings : research report update, Apr. 18, 2003.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Variant title:
Genentech announces 1Q03 earnings : research report update, Apr. 18, 2003.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Amgen (AMGN) 1Q03 update
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867550 / 2003-10-07
Date of Publication:
May 5, 2003
Date of Creation:
2003
Title:
Amgen (AMGN) 1Q03 update : research report update, May 5, 2003.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Variant title:
Amgen (AMGN) 1Q03 update : research report update, May 5, 2003.
Copyright Claimant:
White Mountain Capital, LLC
Names:
AtheroGenics
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005867551 / 2003-10-07
Date of Publication:
April 29, 2003
Date of Creation:
2003
Title:
AtheroGenics : steady progress with AGI-1067 : research report update.
Basis of Claim:
New Matter: additional text.
Description:
1 v.
Number of similar titles:
2
Variant title:
AtheroGenics : steady progress with AGI-1067 : research report update.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Nabi
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005873751 / 2003-11-10
Date of Publication:
September 18, 2003
Date of Creation:
2003
Title:
Nabi : cut to hold.
Application Title:
Nabi biopharmaceuticals: empowering the immune system.
Basis of Claim:
New Matter: additional text.
Description:
2 p.
Variant title:
Nabi : cut to hold.
Other Title:
Nabi biopharmaceuticals: empowering the immune system
Copyright Claimant:
White Mountain Capital
Names:
Genentech
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005873753 / 2003-11-10
Date of Publication:
September 15, 2003
Date of Creation:
2003
Title:
Genentech : too much of a good thing.
Basis of Claim:
New Matter: additional text.
Description:
3 p.
Variant title:
Genentech : too much of a good thing.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Emisphere announces big pharma partner backs out of late stage discussions for oral insulin partnership
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005873754 / 2003-11-10
Date of Publication:
March 7, 2003
Date of Creation:
2003
Title:
Emisphere announces big pharma partner backs out of late stage discussions for oral insulin partnership.
Basis of Claim:
New Matter: additional text.
Description:
2 p.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Atherogenics
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005873755 / 2003-11-10
Date of Publication:
March 7, 2003
Date of Creation:
2003
Title:
Atherogenics : anticipated partnership reinforces positive outlook.
Application Title:
Update March 2003 emisphere.
Basis of Claim:
New Matter: additional text.
Description:
2 p.
Variant title:
Atherogenics : anticipated partnership reinforces positive outlook.
Other Title:
Update March 2003 emisphere
Copyright Claimant:
White Mountain Capital, LLC
Names:
AtheroGenics
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005873756 / 2003-11-10
Date of Publication:
October 24, 2003
Date of Creation:
2003
Title:
AtheroGenics : update on clincial development and partnership discussions.
Basis of Claim:
New Matter: additions.
Description:
2 p.
Number of similar titles:
2
Variant title:
AtheroGenics : update on clincial development and partnership discussions.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Amgen (AMGN) 3Q03 update
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005900981 / 2004-01-21
Date of Publication:
November 7, 2003
Date of Creation:
2003
Title:
Amgen (AMGN) 3Q03 update : reiterate hold rating.
Application Title:
Amgen: 3Q03 update.
Basis of Claim:
New Matter: additions.
Previous Registration:
Preexisting material: Head of the class: outlook for four large-cap biopharmaceutical companies.
Description:
2 p.
Variant title:
Amgen (AMGN) 3Q03 update : reiterate hold rating
Other Title:
Amgen: 3Q03 update
Head of the class: outlook for four large-cap biopharmaceutical companies
Head of the class: outlook for four large-cap biopharmaceutical companies
Copyright Claimant:
White Mountain Capital, LLC
Names:
CV therapeutics (CVTX)
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005900982 / 2004-01-21
Date of Publication:
October 29, 2003
Date of Creation:
2003
Title:
CV therapeutics (CVTX)
Description:
1 v.
Copyright Claimant:
White Mountain Capital, LLC
Names:
Telik
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005900983 / 2004-01-21
Date of Publication:
November 6, 2003
Date of Creation:
2003
Title:
Telik : 3Q03 update.
Basis of Claim:
New Matter: added text.
Previous Registration:
Preexisting material: Upward bound: evaluation of two small-cap biotechnology companies.
Description:
3 p.
Variant title:
Telik : 3Q03 update
Other Title:
Upward bound: evaluation of two small-cap biotechnology companies
Copyright Claimant:
White Mountain Capital, LLC
Names:
CV therapeutics (CVTX) upgraded to buy
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0005900984 / 2004-01-21
Date of Publication:
December 12, 2003
Date of Creation:
2003
Title:
CV therapeutics (CVTX) upgraded to buy.
Basis of Claim:
New Matter: added text.
Previous Registration:
Preexisting material: CV therapeutics: company evaluation.
Description:
1 p.
Other Title:
CV therapeutics: company evaluation
Copyright Claimant:
White Mountain Capital, LLC
Names:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible. Multiple persons can share the same name.